Insider trade

Director sold ~$1.38M of JAZZ shares in the open market

Traded Oct 1, 2026 · Filed Oct 6, 2026

~$1.38M
Reported value · 6,000 sh @ $230.33: 346K
Holds after · shares reported: +1.3%
stock since the trade · S&P 500 +1.4%, $233.01 → $236.04 on Oct 5

Why it stands out

A board member of Jazz Pharmaceuticals sold $1.38M of Jazz Pharmaceuticals shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 1, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 6, 2026

Director$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,381,980

Shares × reported transaction price

Timing vs results

59 days after results of Aug 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $233.01 on Oct 1, 2026, 78% above its 52-week low and 11% below its high, after an 8% drop over the previous 30 trading days

52-week range $131.16 (Nov 7, 2025) to $261.62 (Aug 4, 2026), 78% of the way up, from 249 adjusted closes. 30 trading days earlier: $252.16 on Aug 19, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193210-26-000028
Filed / recorded: Oct 6, 2026, 12:18 AM UTC
Added to OQRO: Oct 6, 2026, 7:59 PM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: Jazz Pharmaceuticals plc
Issuer CIK: 1232524
Ticker: JAZZ
Reporting person: Bruce C Cozadd
Relationship: Director
Security: Ordinary Shares
Table: Non-derivative (Table I)
Transaction date: Oct 1, 2026
Transaction code: S
Shares / units: 6,000
Price per share: $230.33
Acquired / disposed: Disposed (D)
Shares owned after: 345,875
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.

Around the same time

Officer sold ~$289K of Jazz Pharmaceuticals

Scheduled in advance3w ago

1,967Shares · @ $246.81

4w ago

Routine share withholding; mechanical by default.

More Official record

CEO sold ~$486K of Jazz Pharmaceuticals

Scheduled in advance4w ago